NCT05540496View on ClinicalTrials.gov

Ocular, Periocular and Cutaneous Tolerance and Efficacy of Formula 2039002 10 in Patients With Palpebral Eczema

CompletedOBSERVATIONAL
Enrollment

41

Participants

Timeline

Start Date

January 11, 2021

Primary Completion Date

April 17, 2021

Study Completion Date

April 17, 2021

Conditions
Eczema Eyelid
Trial Locations (2)

Unknown

LTD Health, Batumi

LTD Kutaisi Primary Health Care centre #1, Kutaisi

Sponsors
All Listed Sponsors
lead

Cosmetique Active International

INDUSTRY

NCT05540496 - Ocular, Periocular and Cutaneous Tolerance and Efficacy of Formula 2039002 10 in Patients With Palpebral Eczema | Biotech Hunter | Biotech Hunter